Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Back

Become EABM
Become Reviewer

Articles Ahead of Print

Hepatitis C Virus Infection and Treatment as Independent Prognostic Factors in Diffuse Large B-Cell Lymphoma Egyptian Patients

Volume:20
Tamer A. Elbedewy, Hossam Eldin A. Elashtokhy, Sherief Abd-Elsalam* and Marwa A. Suliman

Cancer Stem Cells with Overexpression of Neuronal Markers Enhance Chemoresistance and Invasion in Retinoblastoma

Volume:20
Sekaran Balaji, Radhakrishnan Santhi, Usha Kim, Veerappan Muthukkaruppan, Chidambaranathan Gowri Priya and Ayyasamy Vanniarajan*

Vaccine and Cell-Based Therapeutic Approaches in Acute Myeloid Leukemia

Volume:20
Vaibhav Agrawal, Olumide B Gbolahan, Maximilian Stahl, Amer M Zeidan, Mohammad Abu Zaid, Sherif S Farag and Heiko Konig*

The Evolving AML Genomic Landscape: Therapeutic Implications

Volume:20
Sachi Horibata, George Alyateem, Christin B. DeStefano and Michael M. Gottesman*

Overexpression of p62 Induces Autophagy and Promotes Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells through Promoting ERK Signaling Pathway

Volume:20
Qiong Wu, Manlin Xiang, Kun Wang, Zhen Chen, Lu Long, Ya Tao, Yunlai Liang, Yahui Yan, Zhiqiang Xiao, Shiyang Qiu and Bin Yi*

Targeting Different Pathways Using Novel Combination Therapy in Triple Negative Breast Cancer.

Volume:20
Manzoor Mir*, Hina Khan, Umar Mehraj, Safura Nisar, Basharat Bhat and Nisar Wani

CYP1A1 and CYP2D6 Polymorphisms and Susceptibility to Chronic Myelocytic Leukaemia.

Volume:20
Hadeil ME Idris, Hiba B Khalil, Jeremy Mills and Abozer Y. Elderdery*

FLT3 Inhibition in Acute Myeloid Leukaemia – Current Knowledge and Future Prospects

Volume:20
Francesca L Hogan, Victoria Williams and Steven Knapper*

Targeted Drug Therapy to Overcome Chemoresistance in Triple-Negative Breast Cancer

Volume:20
Mamta Kumari, Praveen Thaggikuppe Krishnamurthy* and Piyong Sola

Synthesis and Cytotoxic Activity of Azine Derivatives of 6- Hydroxyxanthanodiene

Volume:20
Margarita E. Neganova, Sergey G. Klochkov, Sergey A. Pukhov, Svetlana V. Afanasieva, Yulia R. Aleksandrova, Ekaterina Yu. Yandulova, Marco Avila-Rodriguez, Liudmila M. Mikhaleva, Vladimir N. Nikolenko, Siva G. Somasundaram, Cecil E. Kirkland and Gjumrakch Aliev*

The Therapeutic Potential of MEK1/2 Inhibitors in the Treatment of Gynecological Cancers: Rational Strategies and Recent Progress

Volume:20
Sadaf Ghanaatgar-Kasbi, Majid Khazaei, Azam Rastgar-Moghadam, Gordon A. Ferns, Seyed Mahdi Hassanian and Amir Avan*

Immune Checkpoint Regulators: A New Era Toward Promising Cancer Therapy

Volume:20
Mohammed Shaaban, Heba Othman, Takwa Ibrahim, Mariam Ali, Mohamed Abdelmoaty, Abdel-Rahman Abdel-Kawi, Ahmed Mostafa, Aya El Nakeeb, Heba Emam and Alaa Refaat*

Strategic combination therapies for ovarian cancer

Volume:20
Xinran Li, Angel SN Ng, Victor CY Mak, Karen KL Chan, Annie NY Cheung and Lydia WT Cheung*

Immune Checkpoint Inhibitors in AML-A New Frontier

Volume:20
Rohit Thummalapalli, Hanna Knaus, Ivana Gojo and Joshua F. Zeidner*

Neoadjuvant Chemotherapy Induces The Appearance Of New Copy Number Aberrations In A Breast Tumor And This Associated With Metastasis

Volume:20
Nikolai V. Litviakov*, Marina K. Ibragimova, Matvey M. Tsyganov, Artem V. Doroshenko, Eugeniy Yu. Garbukov and Elena M. Slonimskaya

HOTAIR Competitively Binds MiRNA330 as a Molecular Sponge to Increase the Resistance of Gastric Cancer to Trastuzumab

Volume:20
Liangyu Bie, Suxia Luo*, Dan Li, Yan Wei, Yu Mu, Xiaobing Chen, Saiqi Wang, Ping Guo and Xiaoyu Lu

Immunotherapy: a potential approach to targeting cancer stem cells

Volume:20
Wenjun Wang, Ling Bai, Dongsheng Xu, Wei Li and Jiuwei Cui*

USP48 sustains chemoresistance and metastasis in ovarian cancer

Volume:20
Xuemeng Lei, Xukun Li, Hongyan Chen and Zhihua Liu*

Autophagy Driven Extracellular Vesicles in the Leukaemic Microenvironment

Volume:20
Rebecca Horton, Thomas Wileman and Stuart A Rushworth*

COVID-19 Pandemic: Experiences in China and Implications for its Prevention and Treatment Worldwide

Volume:20
Ning-Ning Liu*, Jing-Cong Tan, Jingquan Li, Shenghui Li, Yong Cai and Hui Wang

CircRNA SCARB1 Promotes Renal Cell Carcinoma Progression Via Mir- 510-5p/SDC3 Axis

Volume:20
Jijian Sun*, Shijie Pan, Hongquan Cui and Hao Li

VS-5584 Inhibits Human Osteosarcoma Cells Growth by Induction of G1- phase Arrest through Regulating PI3K/mTOR and MAPK Pathways

Volume:20
Jing-yi Sun, Ya-jun Hou, Hai-juan Cui, Cheng Zhang, Ming-feng Yang, Feng-ze Wang, Zheng Sun, Cun-dong Fan, Bao-liang Sun and Jin Rok Oh

Novel Homeodomain Transcription Factor Nkx2.2 in the Brain Tumor Development

Volume:18
Mubeena PM Mariyath, Mehdi Hayat Shahi*, Shirin Farheen, Mohd Tayyab, Nabeela Khanam and Asif Ali

Updated Review and Perspective on 20S Proteasome Inhibitors in the Treatment of Lung Cancer

Volume:20
Sagar O. Rohondia*, Zainab Sabry Othman Ahmed and Q. Ping Dou

Study of Toll-like Receptor 3 Gene Polymorphism as a Novel Risk Factor for HCV-related Hepatocellular Carcinoma in Egypt

Volume:20
Shimaa EL-Sharawy, Osama El- Sayed Negm, Sherief Abd-Elsalam*, Hesham Ahmed EL-Sorogy and Mona Ahmed Helmy Shehata

CDK9: Therapeutic Perspective in HCC Therapy

Volume:20
Jędrzej Borowczak*, Krzysztof Szczerbowski, Ewa Stec, Dariusz Grzanka and Łukasz Szylberg

Fas Ligand Enhances Apoptosis of Human Lung Cancer Cells Cotreated with RIG-I-Like Receptor Agonist and Radiation

Volume:20
Yoshiaki Sato, Hironori Yoshino*, Eichi Tsuruga and Ikuo Kashiwakura

Hypermethylation of Single CpG Dinucleotides at the Promoter of CXCL13 Gene Promoting Cell Migration in Cervical Cancer

Volume:20
Dong Ma , Shao-Bei Fan , Na Hua, Guo-Hua Li, Quan Chang and Xiao Liu *

Idronoxil as an Anticancer Agent: Activity and Mechanisms

Volume:20
Kate Porter*, W. Douglas Fairlie, Olivier Laczka, Frederic Delebecque and John Wilkinson

Withdrawn: The Structural Bioinformatics Analysis of Biophenolic Lignan- Estrogen Receptor Interaction

Volume:17
Farzaneh Mohamadyar-Toupkanlou*, Mina Esfandiari, Mahshid Sadat Kashef-Saberi, Mahboubeh Kabiri Renani and Masoud Soleimani